User talk:Scientificlife

INTERNATIONAL SCIENTIFIC JOURNALS

European Journal of Inflammation is a multidisciplinary peer-reviewed journal published four monthly. The journal is an international forum covering a wide range of topics in inflammation (immunology, pathology, pharmacology and general experimental and clinical medicine) The intention as that the journal should reflect both the experimental and clinical aspects of inflammation. Only articles written in English will be published. The scientific standard is the only criterion for accepting a manuscript for publication. The style should be clear and concise, Excessive use of jargon or unusual abbreviations should be avoided. Contributors must send the Editor in chief three complete copies (as well as an electronic copy to: mailto:pconti@unich.it) of the text, tables and figures. It is essential that they retain one copy of the original manuscript as the Editor does not accept responsibility for damage or loss of papers submitted. Papers are accepted on the understanding that no substantial part has been, or will be published elsewhere, and once they have been accepted they remain the copyright of the journal. Papers not accepted for publication will not be returned to the authors, Preparation of the text Manuscripts should be typewritten (double spacing) on only one side of the paper with 30 mm margins all around and on a separate sheet, should bear the title of the paper, name and postal address of the author, together with the name of the Institution where the work was done. Author’s first names should be initialized. For indexing purposes a small number of key words should be supplied. Generally, papers should be divided into the following parts and in the order indicated (1) Summary about 5% of the length of the paper, (2) Introduction containing the reason for doing the work, (3) Materials and Methods: sufficient information must be included to permit repetition of the experimental work; (4) Results: these should be given concisely; the use of tables and figures to illustrate the same results will only rarely be allowed; (5) Discussion: the presentation of results should be separate from a discussion of their significance, the section should not repeat results, (6) Acknowledgments, if any, (7) References these should be cited in the text by a number in parentheses and listed at the end of the paper in numerical order. Note the following style for journal and book citations: 1. Conti P., X. Pang, W. Boucher, R. Letourneau, M. Reale, R. C. Barbacane, J. Thibault and T. C. Theoliarides. l997 lmpact of Rantes and MCP-l chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120. 2. Robb Ri. and Y. Lin. 1984. T-ceil growth factor purification, interaction with a cellular receptor and in vitro synthesis. In Thymic Hormones and Lymphokines. A.L. Goldstein, ed. Plenum Publishing Corp. New York, p. 274. Abbreviation of titles of Journals should follow the list of journals indexed in INDEX MEDICUS. References to books should include the editor(s), publisher and place of publication. Authors are responsible far the accuracy of their references. Illustration: The Journal recognized the adoption of the SI unit system. All tables and figures should be cited in order in the text, using roman numerals for the tables and Arabic numerals for figures. Tables should have a short title, Illustrations should carry their numbers and the Authors name un the back, written in light pencil; when necessary, “top” should be indicated on the back. To ensure clear reproduction, diagrams, charts, and other line drawings should be drawn in black India ink, and submitted as glossy. black and white photo prints: for half-tone work, good photographic print should be supplied. In both cases, photocopies are not accepted as original artwork. Tables and illustrations should be of a size easily handled, the effect of reduction in size to fit the journal page should be considered. Proof-reading: Page proofs will be submitted to the contributors far minor corrections and should be returned to the Editor within three days. Major alterations from the text cannot be accepted Editorial correspondence: All manuscripts, Letters to the Editor, editorial matters including advertising, back numbers and requests for reprints, should be sent to the Edltor-in-Chief: Prof. Pio Conti, Immunology Division, Department of Oncology and Neuroscience, University of Chieti, Via dei Vestini - 66100 Chieti Italy. Tel: +39-333-3580438; +39-0871-3555293; Fax: +39-0871-561635 e-mails: mailto:pconti@unich.it or mailto:biolife_sas@yahoo.it Official Website: http://www.biolifesas.org

International Journal of Immunopathology and Pharmacology is published every three months. The journal publishes original papers describing research in the fields of immunology, pathology, pharmacology and general experimental and clinical medicine related to immunology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology and also advances in the understanding of the pathology and pharmacology of the immune system. OnIy articles written in English will be published. The scientific standard is the only criterion for accepting a manuscript for publication. The style should be clear and concise. Excessive use jargon or unusual abbreviations should be avoided. Contributors must send three complete copies and an electronic copy (mailto:pconti@unich.it) of the text, tables and figures, and it is essential that they retain one copy of the original manuscript as the Editor does not accept responsibility for damage or loss of papers submitted. Papers are accepted on the understanding that no substantial part has been, or will be published elsewhere, and once they have been accepted they remain the copyright of the journal. Papers not accepted for publication will not be returned to the authors.

Preparation of the text: Manuscripts should be typewritten (double spacing) on only one side of the paper with 30 mm margins all around and on a separate sheet, should bear the title of the paper, name and postal address of the author, together with the name of the Institution where the work was done. Author’s first names should be initialized. For indexing purposes a small number of key words should be supplied. Generally, papers should be divided into the following parts and in the order indicated: (1) Summary: about 5% of the length of the paper; (2) Introduction: containing the reason for doing the work; (3) Materials and Methods: sufficient information must be included to permit repetition of the experimental work; (4) Results: these should be given concisely; together with tables and figures that have clear legends; (5) Discussion: the presentation of results should be separate from a discussion of their significance; the section should not repeat Resul:s; (6) Acknowledgments if any; (7) References: these should be cited in the text by a number in parentheses and listed at the end of the paper in numerical order. Note the following style for journal and book citations: 1. Conti P., X. Pang, W. Boucher, R. Letourneau, M. Reale, RC. Barbacane, J. Thibault and T.C. Theoharides. 1997. Impact of Rantes and MCP-I chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120. 2. Theoharldes T.C., J.M. Donelan, N. Papadopoulou, J. Cao, D. Kempuraj and P. Conti. 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25:563. 3. Robb RJ. and Y. Lin. 1984. T-ceil growth factor purification, interaction with a cellular receptor and in vitro synthesis. In Thymic Hormones and Lymphokines. A.L. Goldstein, ed. Plenum Publishing Corp. New York, p. 274. Abbreviation of titles of Journals should follow the list of journals indexed in INDEX MEDICUS. References to books should include the editor(s), publisher and place of publication. Authors are responsible for the accuracy of their references. Illustrations: The Journal recognizes the adoption of the SI unit system. All tables and figures should be cited in order in the text, using roman numerals for the tables and Arabic numerals for figures. Tables should have a short title. Illustrations should carry their numbers and the Authors name on the back, written in light pencil; when necessary, “top” should be indicated on the back. Tables and illustrations should be of a size easily handled, the effect of reduction in size to fit the journal page should be considered. Proof-reading: Page proofs will be submitted to the contributors for minor corrections and should be returned to the Editor within three days. Major alterations from the text cannot be accepted. Editorial correspondence: All manuscripts, Letters to the Editor, editorial matters including advertising, back numbers and requests for reprints, should be sent to the Edltor-in-Chief: Prof. Pio Conti, Immunology Division, Department of Oncology and Neuroscience, University of Chieti, Via dei Vestini - 66100 Chieti Italy. Tel: +39-333-3580438; +39-0871-3555293; Fax: +39-0871-561635 e-mails: mailto:pconti@unich.it or mailto:biolife_sas@yahoo.it Official Website: http://www.biolifesas.org

Biolifesas
A tag has been placed on Biolifesas, requesting that it be speedily deleted from Wikipedia. This has been done because it is an article about a certain website, blog, forum, or other web content that does not assert the importance or significance of that web location. Please read our criteria for speedy deletion, particularly item 7 under Articles, as well as notability guidelines for websites. Please note that articles must be on notable subjects and should provide references to reliable sources which verify their content.

Please do not remove the speedy deletion tag yourself. To contest the tagging and request that administrators wait a while for you to add contextual material, please affix the template  to the page, and put a note on Talk:Biolifesas. Feel free to leave a note on my talk page if you have any questions about this. -- Finngall  talk  06:06, 2 April 2007 (UTC)